- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 92.44M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 97.53K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 643 sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.04M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.52M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.35M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$2.17M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.47M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $22.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $142.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $186.98M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $6.41M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $6.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.99M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $38.88M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $33.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $157.09M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $194.96M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.48 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$10.57 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.48 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.78 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.27M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.35M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$46.39M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$145K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$44.57M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.8M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.51M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $273K |